{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:41:30Z","timestamp":1790682090267,"version":"4.1.0"},"reference-count":262,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T00:00:00Z","timestamp":1528070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH, NCI K99\/R00 Pathway to Independence Grant","award":["R00 CA178177"],"award-info":[{"award-number":["R00 CA178177"]}]},{"name":"Pennsylvania State Department of Health","award":["4100072566"],"award-info":[{"award-number":["4100072566"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The skeleton is a unique structure capable of providing support for the body. Bone resorption and deposition are controlled in a tightly regulated balance between osteoblasts and osteoclasts with no net bone gain or loss. However, under conditions of disease, the balance between bone resorption and deposition is upset. Osteoblasts play an important role in bone homeostasis by depositing new bone osteoid into resorption pits. It is becoming increasingly evident that osteoblasts additionally play key roles in cancer cell dissemination to bone and subsequent metastasis. Our laboratory has evidence that when osteoblasts come into contact with disseminated breast cancer cells, the osteoblasts produce factors that initially reduce breast cancer cell proliferation, yet promote cancer cell survival in bone. Other laboratories have demonstrated that osteoblasts both directly and indirectly contribute to dormant cancer cell reactivation in bone. Moreover, we have demonstrated that osteoblasts undergo an inflammatory stress response in late stages of breast cancer, and produce inflammatory cytokines that are maintenance and survival factors for breast cancer cells and osteoclasts. Advances in understanding interactions between osteoblasts, osteoclasts, and bone metastatic cancer cells will aid in controlling and ultimately preventing cancer cell metastasis to bone.<\/jats:p>","DOI":"10.3390\/cancers10060182","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T12:14:30Z","timestamp":1528114470000},"page":"182","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":140,"title":["Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts"],"prefix":"10.3390","volume":"10","author":[{"given":"Alison","family":"Shupp","sequence":"first","affiliation":[{"name":"Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexus","family":"Kolb","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimpi","family":"Mukhopadhyay","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6519-9300","authenticated-orcid":false,"given":"Karen","family":"Bussard","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,6,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-012098652-1\/50103-7","article-title":"Structure and development of the skeleton","volume":"Volume 1","author":"Bilezikian","year":"2002","journal-title":"Principles of Bone Biology"},{"key":"ref_2","unstructured":"Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., and Walter, P. (2002). Molecular Biology of the Cell, Garland Science."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"ii27","DOI":"10.1093\/ageing\/afl081","article-title":"The role of cortical bone and its microstructure in bone strength","volume":"35","author":"Augat","year":"2006","journal-title":"Age Ageing"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S8756-3282(02)00850-5","article-title":"Unique alignment and texture of biological apatite crystallites in typical calcified tissues analyzed by microbeam x-ray diffractometer system","volume":"31","author":"Nakano","year":"2002","journal-title":"Bone"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.bioeng.3.1.307","article-title":"Biomechanics of trabecular bone","volume":"3","author":"Keaveny","year":"2001","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10555-007-9109-4","article-title":"The bone microenvironment in metastasis; what is special about bone?","volume":"27","author":"Bussard","year":"2008","journal-title":"Cancer Metastasis Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrc1528","article-title":"Osteoblasts in prostate cancer metastasis to bone","volume":"5","author":"Logothetis","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"ref_9","unstructured":"U.S (2018, May 05). National Institutes of Health, N.C.I. Available online: https:\/\/training.seer.cancer.gov."},{"key":"ref_10","first-page":"421746","article-title":"Biology of bone tissue: Structure, function, and factors that influence bone cells","volume":"2015","author":"Sasso","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Oftadeh, R., Perez-Viloria, M., Villa-Camacho, J.C., Vaziri, A., and Nazarian, A. (2015). Biomechanics and mechanobiology of trabecular bone: A review. J. Biomech. Eng., 137.","DOI":"10.1115\/1.4029176"},{"key":"ref_12","first-page":"S131","article-title":"The cell biology of bone growth","volume":"48","author":"Price","year":"1994","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jlb.66.1.25","article-title":"Adhesion and homing of blood-borne cells in bone marrow microvessels","volume":"66","author":"Mazo","year":"1999","journal-title":"J. Leukoc. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.abb.2014.05.003","article-title":"Osteoblast and osteocyte: Games without frontiers","volume":"561","author":"Capulli","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jbmr.320","article-title":"The amazing osteocyte","volume":"26","author":"Bonewald","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/8756-3282(95)00444-0","article-title":"Osteocyte density changes in aging and osteoporosis","volume":"18","author":"Mullender","year":"1996","journal-title":"Bone"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/B978-012098652-1\/50109-8","article-title":"Cells of bone: Osteoclast generation","volume":"Volume 1","author":"Bilezikian","year":"2002","journal-title":"Principles of Bone Biology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1084952102000587","article-title":"Formation and function of the ruffled border in osteoclasts","volume":"13","author":"Stenbeck","year":"2002","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.1016\/S0021-9258(18)67143-1","article-title":"Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-sepharose","volume":"261","author":"Hauschka","year":"1986","journal-title":"J. Biol. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/153537020122600603","article-title":"Mesenchymal stem cells","volume":"226","author":"Minguell","year":"2001","journal-title":"Exp. Biol. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/10454411920030030501","article-title":"Concepts of osteoblast growth and differentiation: Basis for modulation of bone cell development and tissue formation","volume":"3","author":"Lian","year":"1992","journal-title":"Crit. Rev. Oral Biol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e00366","DOI":"10.1042\/BSR20160150","article-title":"Rank-rankl signalling in cancer","volume":"36","author":"Renema","year":"2016","journal-title":"Biosci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.4110\/in.2018.18.e8","article-title":"Regulation of osteoclast differentiation by cytokine networks","volume":"18","author":"Amarasekara","year":"2018","journal-title":"Immune Netw."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.3892\/mmr.2015.4328","article-title":"Effects of intermedin on proliferation, apoptosis and the expression of opg\/rankl\/m-csf in the mc3t3-e1 osteoblast cell line","volume":"12","author":"Ren","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1538::AID-CNCR3>3.0.CO;2-G","article-title":"Bone turnover and biochemical markers in malignancy","volume":"80","author":"Kanis","year":"1997","journal-title":"Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1074\/jbc.M805280200","article-title":"Cathepsin k activity-dependent regulation of osteoclast actin ring","volume":"284","author":"Wilson","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/(SICI)1521-1878(199810)20:10<837::AID-BIES9>3.0.CO;2-D","article-title":"How the osteoclast degrades bone","volume":"20","author":"Blair","year":"1998","journal-title":"Bioessays"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jcb.10746","article-title":"Breast cancer cells induce osteoblast apoptosis: A possible contributor to bone degradation","volume":"91","author":"Mastro","year":"2004","journal-title":"J. Cell. Biochem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fcimb.2015.00085","article-title":"Staphylococcus aureus vs. Osteoblast: Relationship and consequences in osteomyelitis","volume":"5","author":"Josse","year":"2015","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/art.23159","article-title":"Phenotypic characterization of osteoblasts from the sclerotic zones of osteoarthritic subchondral bone","volume":"58","author":"Sanchez","year":"2008","journal-title":"Arthritis Rheum."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Sanchez, C., Mazzucchelli, G., Lambert, C., Comblain, F., DePauw, E., and Henrotin, Y. (2018). Comparison of secretome from osteoblasts derived from sclerotic versus non-sclerotic subchondral bone in oa: A pilot study. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0194591"},{"key":"ref_32","first-page":"103","article-title":"Mechanisms of preferential metastasis of breast cancer to bone","volume":"9","author":"Yoneda","year":"1996","journal-title":"Int. J. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Hamza, T., and Li, B. (2014). Differential responses of osteoblasts and macrophages upon Staphylococcus aureus infection. BMC Microbiol., 14.","DOI":"10.1186\/s12866-014-0207-5"},{"key":"ref_34","unstructured":"Weber, A., Chan, P.M.B., and Wen, C. (2017). Do immune cells lead the way in subchondral bone disturbance in osteoarthritis?. Prog. Biophys. Mol. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"7197598","DOI":"10.1155\/2017\/7197598","article-title":"Extracellular vesicles from adipose-derived mesenchymal stem cells downregulate senescence features in osteoarthritic osteoblasts","volume":"2017","author":"Guillen","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1086\/374554","article-title":"Prosthetic joint infections: Bane of orthopedists, challenge for infectious disease specialists","volume":"36","author":"Lentino","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"510","DOI":"10.7861\/clinmedicine.4-6-510","article-title":"Bone and joint infection","volume":"4","author":"Berendt","year":"2004","journal-title":"Clin. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1007\/s11999-017-5507-2","article-title":"Osteomyelitis risk in patients with transfemoral amputations treated with osseointegration prostheses","volume":"475","author":"Tillander","year":"2017","journal-title":"Clin. Orthop. Relat. Res."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Kellesarian, S.V., Javed, F., and Romanos, G.E. (2018). Osteomyelitis arising around osseointegrated dental implants: A systematic review. Implant Dent.","DOI":"10.1097\/ID.0000000000000715"},{"key":"ref_40","first-page":"435","article-title":"Mandibular osteomyelitis associated with dental implants. A case series","volume":"9","author":"Semel","year":"2016","journal-title":"Eur. J. Oral Implantol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-94-007-0940-9_7","article-title":"Adhesion mechanisms of staphylococci","volume":"715","author":"Heilmann","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2106\/00004623-200506000-00022","article-title":"Internalization of bacteria by osteoblasts in a patient with recurrent, long-term osteomyelitis. A case report","volume":"87","author":"Bosse","year":"2005","journal-title":"J. Bone Jt. Surg. Am."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"728619","DOI":"10.1155\/2014\/728619","article-title":"The macrophage inflammatory proteins mip1alpha (ccl3) and mip2alpha (cxcl2) in implant-associated osteomyelitis: Linking inflammation to bone degradation","volume":"2014","author":"Dapunt","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1128\/IAI.68.9.5075-5083.2000","article-title":"Induction of colony-stimulating factor expression following staphylococcus or salmonella interaction with mouse or human osteoblasts","volume":"68","author":"Bost","year":"2000","journal-title":"Infect. Immun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.micinf.2004.04.008","article-title":"Regulation of chemokine gene expression and secretion in staphylococcus aureus-infected osteoblasts","volume":"6","author":"Wright","year":"2004","journal-title":"Microbes Infect."},{"key":"ref_46","first-page":"189","article-title":"Staphylococcus aureus regulates secretion of interleukin-6 and monocyte chemoattractant protein-1 through activation of nuclear factor kappab signaling pathway in human osteoblasts","volume":"15","author":"Ning","year":"2011","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1128\/IAI.70.8.4075-4082.2002","article-title":"Bacterium-induced cxcl10 secretion by osteoblasts can be mediated in part through toll-like receptor 4","volume":"70","author":"Gasper","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1128\/IAI.00228-08","article-title":"Staphylococcus aureus induces expression of receptor activator of nf-kappab ligand and prostaglandin e2 in infected murine osteoblasts","volume":"76","author":"Somayaji","year":"2008","journal-title":"Infect. Immun."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Widaa, A., Claro, T., Foster, T.J., O'Brien, F.J., and Kerrigan, S.W. (2012). Staphylococcus aureus protein a plays a critical role in mediating bone destruction and bone loss in osteomyelitis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0040586"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/jcb.22799","article-title":"Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer","volume":"111","author":"Bussard","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.yexcr.2007.09.021","article-title":"Metastatic breast cancer induces an osteoblast inflammatory response","volume":"314","author":"Kinder","year":"2008","journal-title":"Exp. Cell Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"160265","DOI":"10.1155\/2012\/160265","article-title":"Changes in cytokines of the bone microenvironment during breast cancer metastasis","volume":"2012","author":"Sosnoski","year":"2012","journal-title":"Int. J. Breast Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Claro, T., Widaa, A., O\u2019Seaghdha, M., Miajlovic, H., Foster, T.J., O\u2019Brien, F.J., and Kerrigan, S.W. (2011). Staphylococcus aureus protein a binds to osteoblasts and triggers signals that weaken bone in osteomyelitis. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0018748"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Sanchez, C.J., Ward, C.L., Romano, D.R., Hurtgen, B.J., Hardy, S.K., Woodbury, R.L., Trevino, A.V., Rathbone, C.R., and Wenke, J.C. (2013). Staphylococcus aureus biofilms decrease osteoblast viability, inhibits osteogenic differentiation, and increases bone resorption in vitro. BMC Musculoskelet. Disord., 14.","DOI":"10.1186\/1471-2474-14-187"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Rasigade, J.P., Trouillet-Assant, S., Ferry, T., Diep, B.A., Sapin, A., Lhoste, Y., Ranfaing, J., Badiou, C., Benito, Y., and Bes, M. (2013). Psms of hypervirulent staphylococcus aureus act as intracellular toxins that kill infected osteoblasts. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0063176"},{"key":"ref_56","unstructured":"Fitzgerald, K.A., O\u2019Neill, L.A.J., Gearing, A.J.H., and Callard, R.E. (2001). The Cytokine Facts Book, Academic Press. [2nd ed.]."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/art.33445","article-title":"Regulation of subchondral bone osteoblast metabolism by cyclic compression","volume":"64","author":"Sanchez","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Bianco, D., Todorov, A., Cengic, T., Pagenstert, G., Scharen, S., Netzer, C., Hugle, T., and Geurts, J. (2018). Alterations of subchondral bone progenitor cells in human knee and hip osteoarthritis lead to a bone sclerosis phenotype. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19020475"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Martineau, X., Abed, E., Martel-Pelletier, J., Pelletier, J.P., and Lajeunesse, D. (2017). Alteration of wnt5a expression and of the non-canonical wnt\/pcp and wnt\/pkc-ca2+ pathways in human osteoarthritis osteoblasts. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0180711"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.bone.2006.03.016","article-title":"Opg\/membranous\u2014Rankl complex is internalized via the clathrin pathway before a lysosomal and a proteasomal degradation","volume":"39","author":"Tat","year":"2006","journal-title":"Bone"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(00)49915-0","article-title":"The distribution of secondary growths in cancer of the breast","volume":"133","author":"Paget","year":"1889","journal-title":"Lancet"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1158\/1078-0432.CCR-05-1806","article-title":"Kinetics of metastatic breast cancer cell trafficking in bone","volume":"12","author":"Phadke","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e007258","DOI":"10.1136\/bmjopen-2014-007258","article-title":"Ibandronate to treat skeletal-related events and bone pain in metastatic bone disease or multiple myeloma: A meta-analysis of randomised clinical trials","volume":"5","author":"Geng","year":"2015","journal-title":"BMJ Open"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrc3793","article-title":"Mechanisms of disseminated cancer cell dormancy: An awakening field","volume":"14","author":"Sosa","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1002\/jbmr.2300","article-title":"Prostate cancer cells preferentially home to osteoblast-rich areas in the early stages of bone metastasis: Evidence from in vivo models","volume":"29","author":"Wang","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Belic, J., Graf, R., Bauernhofer, T., Cherkas, Y., Ulz, P., Waldispuehl-Geigl, J., Perakis, S., Gormley, M., Patel, J., and Li, W. (2018). Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide. Int. J. Cancer.","DOI":"10.1002\/ijc.31397"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3332\/ecancer.2017.715","article-title":"Bone metastasis risk factors in breast cancer","volume":"11","author":"Pulido","year":"2017","journal-title":"Ecancermedicalscience"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/leu.2013.258","article-title":"Relationship between initial clinical presentation and the molecular cytogenetic classification of myeloma","volume":"28","author":"Greenberg","year":"2014","journal-title":"Leukemia"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"22205","DOI":"10.1038\/srep22205","article-title":"Corrigendum: Natural history of non-small-cell lung cancer with bone metastases","volume":"6","author":"Santini","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"18670","DOI":"10.1038\/srep18670","article-title":"Natural history of non-small-cell lung cancer with bone metastases","volume":"5","author":"Daniele","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4143\/crt.2007.39.3.104","article-title":"Bone metastasis from primary hepatocellular carcinoma: Characteristics of soft tissue formation","volume":"39","author":"Kim","year":"2007","journal-title":"Cancer Res. Treat."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Chen, S.-C., and Kuo, P.-L. (2016). Bone metastasis from renal cell carcinoma. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17060987"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1210\/jc.2005-2838","article-title":"Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy","volume":"91","author":"Durante","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","article-title":"Metastatic behavior of breast cancer subtypes","volume":"28","author":"Kennecke","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10549-016-3782-3","article-title":"The incidence of bone metastasis after early-stage breast cancer in canada","volume":"156","author":"Liede","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.6004\/jnccn.2009.0080","article-title":"The science and practice of bone health in oncology: Managing bone loss and metastasis in patients with solid tumors","volume":"7","author":"Lipton","year":"2009","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Manders, K., van de Poll-Franse, L.V., Creemers, G.J., Vreugdenhil, G., van der Sangen, M.J., Nieuwenhuijzen, G.A., Roumen, R.M., and Voogd, A.C. (2006). Clinical management of women with metastatic breast cancer: A descriptive study according to age group. BMC Cancer, 6.","DOI":"10.1186\/1471-2407-6-179"},{"key":"ref_79","unstructured":"Mundy, G.R. (1999). Bone Remodeling and Its Disorders, Martin Dunitz Ltd."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G","article-title":"Skeletal complications of malignancy","volume":"80","author":"Coleman","year":"1997","journal-title":"Cancer"},{"key":"ref_81","first-page":"917","article-title":"Tumor-derived platelet-derived growth factor-bb plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer","volume":"62","author":"Yi","year":"2002","journal-title":"Cancer Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"10954","DOI":"10.1073\/pnas.1830978100","article-title":"A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases","volume":"100","author":"Yin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_83","first-page":"18","article-title":"Cancer and bone","volume":"19","author":"Guise","year":"1998","journal-title":"Endocr. Rev."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: Causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/bdd.770","article-title":"Integrated model for denosumab and ibandronate pharmacodynamics in postmenopausal women","volume":"32","author":"Marathe","year":"2011","journal-title":"Biopharm. Drug Dispos."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/hae.13384","article-title":"The role of sclerostin\/dickkopf-1 and receptor activator of nuclear factor kb ligand\/osteoprotegerin signalling pathways in the development of osteoporosis in patients with haemophilia a and b: A cross-sectional study","volume":"24","author":"Anagnostis","year":"2018","journal-title":"Haemoph. Off. J. World Fed. Hemoph."},{"key":"ref_87","first-page":"92","article-title":"Osteoporosis: A review of treatment options","volume":"43","author":"Tu","year":"2018","journal-title":"Pharm. Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/1097-0142(20000615)88:12+<2892::AID-CNCR2>3.0.CO;2-Y","article-title":"Molecular mechanisms of osteolytic bone metastases","volume":"88","author":"Guise","year":"2000","journal-title":"Cancer"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1210\/endo.141.9.7634","article-title":"Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function","volume":"141","author":"Udagawa","year":"2000","journal-title":"Endocrinology"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar2165","article-title":"Biology of rank, rankl, and osteoprotegerin","volume":"9","author":"Boyce","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"ref_91","first-page":"4418","article-title":"The bisphosphonate ibandronate promotes apoptosis in mda-mb-231 human breast cancer cells in bone metastases","volume":"61","author":"Hiraga","year":"2001","journal-title":"Cancer Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/8756-3282(94)90703-X","article-title":"Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer","volume":"15","author":"Taube","year":"1994","journal-title":"Bone"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"6213s","DOI":"10.1158\/1078-0432.CCR-06-1007","article-title":"Basic mechanisms responsible for osteolytic and osteoblastic bone metastases","volume":"12","author":"Guise","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Marino, S., and Roodman, G.D. (2017). Multiple myeloma and bone: The fatal interaction. Cold Spring Harbor Perspect. Med.","DOI":"10.1101\/cshperspect.a031286"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1200\/JCO.1989.7.12.1909","article-title":"Mechanisms of bone destruction in multiple myeloma: The importance of an unbalanced process in determining the severity of lytic bone disease","volume":"7","author":"Bataille","year":"1989","journal-title":"J. Clin. Oncol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1182\/blood-2005-03-1080","article-title":"Il-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma","volume":"106","author":"Ehrlich","year":"2005","journal-title":"Blood"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/leu.2013.385","article-title":"Bone marrow monocyte-\/macrophage-derived activin a mediates the osteoclastogenic effect of il-3 in multiple myeloma","volume":"28","author":"Silbermann","year":"2014","journal-title":"Leukemia"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1038\/leu.2017.152","article-title":"Genetic deletion of sost or pharmacological inhibition of sclerostin prevent multiple myeloma-induced bone disease without affecting tumor growth","volume":"31","author":"Anderson","year":"2017","journal-title":"Leukemia"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/nm.3961","article-title":"Excess tgf-beta mediates muscle weakness associated with bone metastases in mice","volume":"21","author":"Waning","year":"2015","journal-title":"Nat. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bone.2016.07.007","article-title":"Combined treatment with a transforming growth factor beta inhibitor (1d11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone disease","volume":"91","author":"Nyman","year":"2016","journal-title":"Bone"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.1182\/blood-2011-04-346775","article-title":"Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease","volume":"118","author":"Jin","year":"2011","journal-title":"Blood"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.bone.2013.01.012","article-title":"In vivo and in vitro effects of a novel anti-dkk1 neutralizing antibody in multiple myeloma","volume":"53","author":"Pozzi","year":"2013","journal-title":"Bone"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1158\/1541-7786.MCR-16-0242-T","article-title":"Ezh2 or hdac1 inhibition reverses multiple myeloma-induced epigenetic suppression of osteoblast differentiation","volume":"15","author":"Adamik","year":"2017","journal-title":"Mol. Cancer Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/SPC.0b013e328349c524","article-title":"Bone effects of cancer therapies: Pros and cons","volume":"5","author":"Silbermann","year":"2011","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1182\/blood-2014-11-568881","article-title":"Pathogenesis beyond the cancer clone(s) in multiple myeloma","volume":"125","author":"Bianchi","year":"2015","journal-title":"Blood"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/bjh.13056","article-title":"A phase ib multicentre dose-determination study of bhq880 in combination with anti-myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related events","volume":"167","author":"Iyer","year":"2014","journal-title":"Br. J. Haematol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1182\/blood-2008-11-191577","article-title":"Anti-dkk1 mab (bhq880) as a potential therapeutic agent for multiple myeloma","volume":"114","author":"Fulciniti","year":"2009","journal-title":"Blood"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Kocemba, K.A., Groen, R.W., van Andel, H., Kersten, M.J., Mahtouk, K., Spaargaren, M., and Pals, S.T. (2012). Transcriptional silencing of the wnt-antagonist dkk1 by promoter methylation is associated with enhanced wnt signaling in advanced multiple myeloma. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0030359"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.bbrc.2018.01.144","article-title":"Cbfa2t2 is required for bmp-2-induced osteogenic differentiation of mesenchymal stem cells","volume":"496","author":"Huang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/1097-0142(19830301)51:5<918::AID-CNCR2820510526>3.0.CO;2-J","article-title":"Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma special reference to osteomalacia","volume":"51","author":"Charhon","year":"1983","journal-title":"Cancer"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1464-410X.1991.tb15260.x","article-title":"Morphometric evidence for bone resorption and replacement in prostate cancer","volume":"68","author":"Clarke","year":"1991","journal-title":"Br. J. Urol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1634\/theoncologist.8-2-161","article-title":"Clinical approaches to osseous metastases in prostate cancer","volume":"8","author":"Morris","year":"2003","journal-title":"Oncologist"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10555-017-9719-4","article-title":"Current perspectives on bone metastases in castrate-resistant prostate cancer","volume":"37","author":"Logothetis","year":"2018","journal-title":"Cancer Metastasis Rev."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bone.2017.01.004","article-title":"Disruption of collagen\/apatite alignment impairs bone mechanical function in osteoblastic metastasis induced by prostate cancer","volume":"97","author":"Sekita","year":"2017","journal-title":"Bone"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.biomaterials.2014.10.025","article-title":"Abnormal arrangement of a collagen\/apatite extracellular matrix orthogonal to osteoblast alignment is constructed by a nanoscale periodic surface structure","volume":"37","author":"Matsugaki","year":"2015","journal-title":"Biomaterials"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"252ra122","DOI":"10.1126\/scitranslmed.3009332","article-title":"Prostate cancer cell-stromal cell crosstalk via fgfr1 mediates antitumor activity of dovitinib in bone metastases","volume":"6","author":"Wan","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_117","first-page":"2587","article-title":"Prostate cancer cells-osteoblast interaction shifts expression of growth\/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts","volume":"9","author":"Fizazi","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF00431541","article-title":"Immunocytochemical detection and phenotypic characterization of micrometastatic tumour cells in bone marrow of patients with prostate cancer","volume":"22","author":"Oberneder","year":"1994","journal-title":"Urol. Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jbo.2016.03.007","article-title":"The role of osteoblasts in bone metastasis","volume":"5","author":"Ottewell","year":"2016","journal-title":"J. Bone Oncol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/ijc.23602","article-title":"Tumor expressed pthrp facilitates prostate cancer-induced osteoblastic lesions","volume":"123","author":"Liao","year":"2008","journal-title":"Int. J. Cancer"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1210\/me.2006-0346","article-title":"Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation","volume":"21","author":"Clines","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"ref_122","first-page":"753","article-title":"Mechanisms of osteolytic and osteoblastic skeletal lesions","volume":"4","author":"Silbermann","year":"2015","journal-title":"Bonekey Rep."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/cncr.22996","article-title":"A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer","volume":"110","author":"Carducci","year":"2007","journal-title":"Cancer"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2002.08.028","article-title":"Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: Safety and pharmacokinetics","volume":"20","author":"Carducci","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1200\/JCO.2003.04.176","article-title":"Effect of endothelin-a receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer; a randomized, phase ii, placebo-controlled trial","volume":"21","author":"Carducci","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S1470-2045(13)70294-8","article-title":"Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (swog s0421): A randomised phase 3 trial","volume":"14","author":"Quinn","year":"2013","journal-title":"Lancet Oncol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1158\/1078-0432.CCR-16-2955","article-title":"Radium-223 inhibits osseous prostate cancer growth by dual targeting of cancer cells and bone microenvironment in mouse models","volume":"23","author":"Suominen","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1359\/JBMR.041109","article-title":"Skeletal localization and neutralization of the sdf-1 (cxcl12)\/cxcr4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo","volume":"20","author":"Sun","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/pros.23489","article-title":"Osteoblast-derived factors promote metastatic potential in human prostate cancer cells, in part via non-canonical transforming growth factor beta (tgfbeta) signaling","volume":"78","author":"Karlsson","year":"2018","journal-title":"Prostate"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10585-010-9330-3","article-title":"Localization of mcp-1, vegf, and il-6 in the bone microenvironment of mice bearing metastatic breast cancer","volume":"27","author":"Bussard","year":"2010","journal-title":"Clin. Exp. Metas"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.canlet.2017.11.016","article-title":"Dual targeting c-met and vegfr2 in osteoblasts suppresses growth and osteolysis of prostate cancer bone metastasis","volume":"414","author":"Lee","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_132","unstructured":"Kolb, A.D., Shupp, A.B., Mukhopadhyay, D., and Bussard, K.M. (2018). Thomas Jefferson University, Philadelphia, PA, USA, Unpublished data."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1158\/0008-5472.CAN-03-3437","article-title":"Cx3cr1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells","volume":"64","author":"Shulby","year":"2004","journal-title":"Cancer Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"R91","DOI":"10.1186\/bcr3016","article-title":"The chemokine receptor cx(3)cr1 is directly involved in the arrest of breast cancer cells to the skeleton","volume":"13","author":"Zhang","year":"2011","journal-title":"Breast Cancer Res."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1158\/1541-7786.MCR-16-0013","article-title":"Novel small-molecule cx3cr1 antagonist impairs metastatic seeding and colonization of breast cancer cells","volume":"14","author":"Shen","year":"2016","journal-title":"Mol. Cancer Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"36520","DOI":"10.1038\/srep36520","article-title":"Axl is required for tgf-beta2-induced dormancy of prostate cancer cells in the bone marrow","volume":"6","author":"Yumoto","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1158\/1078-0432.CCR-16-1316","article-title":"Therapeutic activity of anti-axl antibody against triple-negative breast cancer patient-derived xenografts and metastasis","volume":"23","author":"Leconet","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1593\/neo.91384","article-title":"Gas6\/axl axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche","volume":"12","author":"Shiozawa","year":"2010","journal-title":"Neoplasia"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"25698","DOI":"10.18632\/oncotarget.8365","article-title":"Endogenous gas6 and mer receptor signaling regulate prostate cancer stem cells in bone marrow","volume":"7","author":"Jung","year":"2016","journal-title":"Oncotarget"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1158\/1078-0432.CCR-16-1298","article-title":"Gas6\/axl signaling regulates self-renewal of chronic myelogenous leukemia stem cells by stabilizing beta-catenin","volume":"23","author":"Jin","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Yu-Lee, L.Y., Yu, G., Lee, Y.C., Lin, S.C., Pan, J., Pan, T., Yu, K.J., Liu, B., Creighton, C.J., and Rodriguez-Canales, J. (2018). Osteoblast-secreted factors mediate dormancy of metastatic prostate cancer in the bone via activation of the tgfbetariii-p38mapk-ps249\/t252rb pathway. Cancer Res.","DOI":"10.1158\/0008-5472.CAN-17-1051"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1084\/jem.20110840","article-title":"Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone","volume":"208","author":"Kobayashi","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"8983","DOI":"10.1038\/ncomms9983","article-title":"Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche","volume":"6","author":"Lawson","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/ncb2767","article-title":"The perivascular niche regulates breast tumour dormancy","volume":"15","author":"Ghajar","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.addr.2014.01.001","article-title":"The need for complex 3d culture models to unravel novel pathways and identify accurate biomarkers in breast cancer","volume":"69","author":"Weigelt","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1242\/dmm.030403","article-title":"Mouse models of metastasis: Progress and prospects","volume":"10","author":"Tracey","year":"2017","journal-title":"Dis. Models Mech."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.molonc.2013.02.009","article-title":"Rebuilding cancer metastasis in the mouse","volume":"7","author":"Saxena","year":"2013","journal-title":"Mol. Oncol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1600-0463.2008.01033.x","article-title":"Cancer micrometastasis and tumour dormancy","volume":"116","author":"Wikman","year":"2008","journal-title":"APMIS Acta Pathol. Microbiol. Immunol. Scand."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMoa050434","article-title":"A pooled analysis of bone marrow micrometastasis in breast cancer","volume":"353","author":"Braun","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_150","first-page":"2162","article-title":"Persistence of solitary mammary carcinoma cells in a secondary site: A possible contributor to dormancy","volume":"62","author":"Naumov","year":"2002","journal-title":"Cancer Res."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10585-015-9710-9","article-title":"Dormancy and growth of metastatic breast cancer cells in a bone-like microenvironment","volume":"32","author":"Sosnoski","year":"2015","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1158\/0008-5472.CAN-07-6849","article-title":"Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton","volume":"68","author":"Barkan","year":"2008","journal-title":"Cancer Res."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1158\/0008-5472.CAN-09-2356","article-title":"Metastatic growth from dormant cells induced by a col-I enriched fibrotic environment","volume":"70","author":"Barkan","year":"2010","journal-title":"Cancer Res."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Battula, V.L., Le, P.M., Sun, J.C., Nguyen, K., Yuan, B., Zhou, X., Sonnylal, S., McQueen, T., Ruvolo, V., and Michel, K.A. (2017). Aml-induced osteogenic differentiation in mesenchymal stromal cells supports leukemia growth. JCI Insight, 2.","DOI":"10.1172\/jci.insight.90036"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1182\/blood-2011-11-389957","article-title":"Human extramedullary bone marrow in mice: A novel in vivo model of genetically controlled hematopoietic microenvironment","volume":"119","author":"Chen","year":"2012","journal-title":"Blood"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"19638","DOI":"10.1073\/pnas.1208384109","article-title":"Implantable microenvironments to attract hematopoietic stem\/cancer cells","volume":"109","author":"Lee","year":"2012","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1021\/acsbiomaterials.6b00101","article-title":"Three-dimensional printing of bone extracellular matrix for craniofacial regeneration","volume":"2","author":"Hung","year":"2016","journal-title":"ACS Biomater. Sci. Eng."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40824-016-0066-2","article-title":"Multiple genetically engineered humanized microenvironments in a single mouse","volume":"20","author":"Lee","year":"2016","journal-title":"Biomater. Res."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"7229","DOI":"10.1158\/0008-5472.CAN-14-1809","article-title":"Bioengineered implantable scaffolds as a tool to study stromal-derived factors in metastatic cancer models","volume":"74","author":"Bersani","year":"2014","journal-title":"Cancer Res."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1210\/en.2016-1606","article-title":"Prostatic acid phosphatase alters the rankl\/opg system and induces osteoblastic prostate cancer bone metastases","volume":"157","author":"Kirschenbaum","year":"2016","journal-title":"Endocrinology"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ccell.2014.11.017","article-title":"The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells","volume":"27","author":"Wang","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.cell.2012.06.035","article-title":"The bmp inhibitor coco reactivates breast cancer cells at lung metastatic sites","volume":"150","author":"Gao","year":"2012","journal-title":"Cell"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/2211-5463.12347","article-title":"Bmp3 expression by osteoblast lineage cells is regulated by canonical wnt signaling","volume":"8","author":"Kokabu","year":"2018","journal-title":"FEBS Open Bio"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.1128\/MCB.24.15.6560-6568.2004","article-title":"Bone morphogenetic protein 2-induced osteoblast differentiation requires smad-mediated down-regulation of cdk6","volume":"24","author":"Ogasawara","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"272","DOI":"10.7150\/ijbs.2929","article-title":"Tgf-\u03b2 and bmp signaling in osteoblast differentiation and bone formation","volume":"8","author":"Chen","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2174\/1568009615666150506092443","article-title":"Bone metastasis: Molecular mechanisms implicated in tumour cell dormancy in breast and prostate cancer","volume":"15","author":"Quayle","year":"2015","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5732\/cjc.010.10582","article-title":"Pre-osteoblastic mc3t3-e1 cells promote breast cancer growth in bone in a murine xenograft model","volume":"30","author":"Bodenstine","year":"2011","journal-title":"Chin. J. Cancer"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Scimeca, M., Antonacci, C., Toschi, N., Giannini, E., Bonfiglio, R., Buonomo, C.O., Pistolese, C.A., Tarantino, U., and Bonanno, E. (2017). Breast osteoblast-like cells: A reliable early marker for bone metastases from breast cancer. Clin. Breast Cancer.","DOI":"10.1016\/j.clbc.2017.11.020"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.1158\/1078-0432.CCR-10-2505","article-title":"Hematopoietic stem cell niche is a potential therapeutic target for bone metastatic tumors","volume":"17","author":"Shiozawa","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/aja.2011.164","article-title":"The prostate cancer bone marrow niche: More than just \u2018fertile soil\u2019","volume":"14","author":"Pedersen","year":"2012","journal-title":"Asian J. Androl."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.0.CO;2-I","article-title":"Mechanisms of bone metastasis","volume":"80","author":"Mundy","year":"1997","journal-title":"Cancer"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI118947","article-title":"Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast-cancer-mediated osteolysis","volume":"98","author":"Guise","year":"1996","journal-title":"J. Clin. Investig."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrrheum.2011.77","article-title":"Cathepsin k: Its skeletal actions and role as a therapeutic target in osteoporosis","volume":"7","author":"Costa","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/nyas.13629","article-title":"A novel role for cathepsin k in periosteal osteoclast precursors during fracture repair","volume":"1415","author":"Walia","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1158\/1535-7163.MCT-07-0234","article-title":"Molecular biology of bone metastasis","volume":"6","author":"Kingsley","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S8756-3282(03)00086-3","article-title":"Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease","volume":"33","author":"Bendre","year":"2003","journal-title":"Bone"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1158\/0008-5472.CAN-05-2630","article-title":"Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kb ligand pathway","volume":"65","author":"Bendre","year":"2005","journal-title":"Cancer Res."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1210\/jcem-55-2-219","article-title":"Quantitative bone histomorphology in humoral hypercalcemia of malignancy: Uncoupling of bone cell activity","volume":"55","author":"Stewart","year":"1982","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10585-004-1867-6","article-title":"Metastatic breast cancer cells suppress osteoblast adhesion and differentiation","volume":"21","author":"Mercer","year":"2004","journal-title":"Clin. Exp. Metas"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1182\/blood-2003-06-1992","article-title":"Il-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cells","volume":"103","author":"Lee","year":"2004","journal-title":"Blood"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.bbrc.2007.03.099","article-title":"Tnf-alpha inhibits bmp-induced osteoblast differentiation through activating sapk\/jnk signaling","volume":"356","author":"Mukai","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood.V83.7.1903.1903","article-title":"High levels of interleukin-6 are associated with low tumor burden and low growth fraction in multiple myeloma","volume":"83","author":"Ballester","year":"1994","journal-title":"Blood"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00432-004-0578-3","article-title":"Expression of receptor activator of nf-kappab ligand (rankl) mrna in human multiple myeloma cells","volume":"130","author":"Heider","year":"2004","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1365-2141.1999.01193.x","article-title":"Expression of interleukin-1beta and tumour necrosis factor-alpha in plasma cells from patients with multiple myeloma","volume":"104","author":"Sati","year":"1999","journal-title":"Br. J. Haematol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1182\/blood.V96.2.671.014k24_671_675","article-title":"Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma","volume":"96","author":"Choi","year":"2000","journal-title":"Blood"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3349\/ymj.2017.58.3.505","article-title":"Cyclized oligopeptide targeting lrp5\/6-dkk1 interaction reduces the growth of tumor burden in a multiple myeloma mouse model","volume":"58","author":"Park","year":"2017","journal-title":"Yonsei Med. J."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10549-013-2488-z","article-title":"The role of intratumoral and systemic il-6 in breast cancer","volume":"138","author":"Dethlefsen","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ccr.2010.12.022","article-title":"Tumor-derived jagged 1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells","volume":"19","author":"Sethi","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1158\/0008-5472.CAN-08-0613","article-title":"Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells","volume":"69","author":"Ara","year":"2009","journal-title":"Cancer Res."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1158\/1535-7163.MCT-11-0264","article-title":"Cabozantinib (xl184), a novel met and vegfr2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth","volume":"10","author":"Yakes","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s10585-014-9680-3","article-title":"Targeting il-6 and rankl signaling inhibits prostate cancer growth in bone","volume":"31","author":"Zheng","year":"2014","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"315103","DOI":"10.1088\/0957-4484\/27\/31\/315103","article-title":"A 3d printed nano bone matrix for characterization of breast cancer cell and osteoblast interactions","volume":"27","author":"Zhu","year":"2016","journal-title":"Nanotechnology"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/(SICI)1097-0215(19970502)71:3<422::AID-IJC20>3.0.CO;2-G","article-title":"Stimulation of interleukin-11 production from osteoblast-like cells by transforming growth factor-beta and tumor cell factors","volume":"71","author":"Morinaga","year":"1997","journal-title":"Int. J. Cancer"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/pros.23270","article-title":"Distinct osteomimetic response of androgen-dependent and independent human prostate cancer cells to mechanical action of fluid flow: Prometastatic implications","volume":"77","author":"Gonzalez","year":"2017","journal-title":"Prostate"},{"key":"ref_195","first-page":"5571","article-title":"Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo","volume":"62","author":"Bendre","year":"2002","journal-title":"Cancer Res."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jss.2006.03.018","article-title":"Involvement of il-8 in cox-2-mediated bone metastases from breast cancer","volume":"134","author":"Singh","year":"2006","journal-title":"J. Surg. Res."},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"McCoy, E.M., Hong, H., Pruitt, H.C., and Feng, X. (2013). Il-11 produced by breast cancer cells augments osteoclastogenesis by sustaining the pool of osteoclast progenitor cells. BMC Cancer, 13.","DOI":"10.1186\/1471-2407-13-16"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10585-008-9226-7","article-title":"Activation of mcp-1\/ccr2 axis promotes prostate cancer growth in bone","volume":"26","author":"Lu","year":"2009","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1038\/sj.onc.1210154","article-title":"Cox-2 involvement in breast cancer metastasis to bone","volume":"26","author":"Singh","year":"2007","journal-title":"Oncogene"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/sj.bjc.6602417","article-title":"Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone","volume":"92","author":"Aldridge","year":"2005","journal-title":"Br. J. Cancer"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1756-9966-31-40","article-title":"In vitro the behaviors of metastasis with suppression of vegf in human bone metastatic lncap-derivative c4-2b prostate cancer cell line","volume":"31","author":"Yang","year":"2012","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1093\/carcin\/bgp227","article-title":"Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer","volume":"30","author":"Chen","year":"2009","journal-title":"Carcinogenesis"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/sj.bjc.6606070","article-title":"Enhancement of osteoclastogenic activity in osteolytic prostate cancer cells by physical contact with osteoblasts","volume":"104","author":"Shiirevnyamba","year":"2011","journal-title":"Br. J. Cancer"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"10020","DOI":"10.1038\/srep10020","article-title":"Cox2 is involved in hypoxia-induced tnf-alpha expression in osteoblast","volume":"5","author":"Xing","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jbo.2014.10.002","article-title":"The sk-n-as human neuroblastoma cell line develops osteolytic bone metastases with increased angiogenesis and cox-2 expression","volume":"3","author":"Tsutsumimoto","year":"2014","journal-title":"J. Bone Oncol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jss.2005.11.582","article-title":"Cox-2 induces il-11 production in human breast cancer cells","volume":"131","author":"Singh","year":"2006","journal-title":"J. Surg. Res."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI3523","article-title":"Tgf-beta signaling blockade inhibits pthrp secretion by breast cancer cells and bone metastases development","volume":"103","author":"Yin","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/nm.1943","article-title":"Imaging transforming growth factor-beta signaling dynamics and therapeutic response in breast cancer bone metastasis","volume":"15","author":"Korpal","year":"2009","journal-title":"Nat. Med."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1158\/0008-5472.CAN-11-3061","article-title":"Bone-derived igf mediates crosstalk between bone and breast cancer cells in bony metastases","volume":"72","author":"Hiraga","year":"2012","journal-title":"Cancer Res."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"6574","DOI":"10.1158\/0008-5472.CAN-12-4692","article-title":"Parathyroid hormone-related protein drives a cd11b+gr1+ cell-mediated positive feedback loop to support prostate cancer growth","volume":"73","author":"Park","year":"2013","journal-title":"Cancer Res."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.cmet.2017.01.001","article-title":"Parathyroid hormone directs bone marrow mesenchymal cell fate","volume":"25","author":"Fan","year":"2017","journal-title":"Cell Metab."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12943-017-0746-0","article-title":"Microrna-124 inhibits bone metastasis of breast cancer by repressing interleukin-11","volume":"17","author":"Cai","year":"2018","journal-title":"Mol. Cancer"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0006-291X(02)02937-6","article-title":"Role of prostaglandin e produced by osteoblasts in osteolysis due to bone metastasis","volume":"300","author":"Ohshiba","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bcp.2014.06.005","article-title":"Trolox inhibits osteolytic bone metastasis of breast cancer through both pge2-dependent and independent mechanisms","volume":"91","author":"Lee","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semcancer.2015.08.010","article-title":"Complexity of cancer protease biology: Cathepsin k expression and function in cancer progression","volume":"35","author":"Verbovsek","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"Esposito, M., Guise, T., and Kang, Y. (2017). The biology of bone metastasis. Cold Spring Harbor Perspect. Med.","DOI":"10.1101\/cshperspect.a031252"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1093\/jnci\/djr362","article-title":"Novel therapies for metastatic castrate-resistant prostate cancer","volume":"103","author":"Dayyani","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10549-015-3624-8","article-title":"Potentiated suppression of dickkopf-1 in breast cancer by combined administration of the mevalonate pathway inhibitors zoledronic acid and statins","volume":"154","author":"Gobel","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.bone.2007.12.006","article-title":"Dkk1-induced inhibition of wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma","volume":"42","author":"Qiang","year":"2008","journal-title":"Bone"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00774-010-0202-3","article-title":"Targeted over-expression of dkk1 in osteoblasts reduces bone mass but does not impair the anabolic response to intermittent pth treatment in mice","volume":"29","author":"Yao","year":"2011","journal-title":"J. Bone Miner. Metab."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S8756-3282(02)00915-8","article-title":"Interleukin-6 and interleukin-11 support human osteoclast formation by a rankl-independent mechanism","volume":"32","author":"Kudo","year":"2003","journal-title":"Bone"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cytogfr.2003.10.005","article-title":"Il-6, rankl, tnf-alpha\/il-1: Interrelations in bone resorption pathophysiology","volume":"15","author":"Padrines","year":"2004","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_223","first-page":"8520","article-title":"Nucleus pulposus cells derived igf-1 and mcp-1 enhance osteoclastogenesis and vertebrae disruption in lumbar disc herniation","volume":"7","author":"Zhu","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/jbmr.2182","article-title":"Bisphosphonates inhibit osteosarcoma-mediated osteolysis via attenuation of tumor expression of mcp-1 and rankl","volume":"29","author":"Ohba","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"D571","DOI":"10.2741\/Graves","article-title":"The expression of monocyte chemoattractant protein-1 and other chemokines by osteoblasts","volume":"4","author":"Graves","year":"1999","journal-title":"Front. Biosci."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/j.1572-0241.2004.30733.x","article-title":"Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus","volume":"99","author":"Koide","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/pros.20464","article-title":"Monocyte chemotactic protein-1 (mcp-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion","volume":"66","author":"Lu","year":"2006","journal-title":"Prostate"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ijc.21291","article-title":"Transactivation of mcp-1\/ccl2 by \u03b2-catenin\/tcf-4 in human breast cancer cells","volume":"118","author":"Mestdagt","year":"2006","journal-title":"Int. J. Cancer"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/ijc.11337","article-title":"Progression of mouse mammary tumors: Mcp-1-tnf-alpha cross regulatory pathway and clonal expression of promalignancy and antimalignancy factors","volume":"106","author":"Neumark","year":"2003","journal-title":"Int J. Cancer"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.yexcr.2005.07.029","article-title":"Cytokines secreted by bone-metastatic breast cancer cells alter the expression pattern of f-actin and reduce focal adhesion plaques in osteoblasts through PI3K","volume":"310","author":"Mercer","year":"2005","journal-title":"Exp. Cell Res."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bone.2005.10.003","article-title":"Regulation of sdf-1 (cxcl12) production by osteoblasts; a possible mechanism for stem cell homing","volume":"38","author":"Jung","year":"2006","journal-title":"Bone"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/pros.20500","article-title":"Expression and activation of alpha v beta 3 integrins by sdf-1\/cxc12 increases the aggressiveness of prostate cancer cells","volume":"67","author":"Sun","year":"2007","journal-title":"Prostate"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"74987","DOI":"10.18632\/oncotarget.20489","article-title":"Cabozantinib-induced osteoblast secretome promotes survival and migration of metastatic prostate cancer cells in bone","volume":"8","author":"Yu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_234","first-page":"3575","article-title":"Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate lncap tumors","volume":"63","author":"Kiyama","year":"2003","journal-title":"Cancer Res."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm.2890","article-title":"Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through wnt16b","volume":"18","author":"Sun","year":"2012","journal-title":"Nat. Med."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1073\/pnas.1618650114","article-title":"Aberrantly expressed lgr4 empowers wnt signaling in multiple myeloma by hijacking osteoblast-derived r-spondins","volume":"114","author":"Ren","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.1073\/pnas.0610299104","article-title":"Targeting the beta-catenin\/tcf transcriptional complex in the treatment of multiple myeloma","volume":"104","author":"Sukhdeo","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1073\/pnas.0305855101","article-title":"Illegitimate wnt signaling promotes proliferation of multiple myeloma cells","volume":"101","author":"Derksen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/jbmr.2371","article-title":"Role of decorin in multiple myeloma (mm) bone marrow microenvironment","volume":"30","author":"Nemani","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"ref_240","first-page":"2731","article-title":"Bisphosphonates: Safety and efficacy in the treatment and prevention of osteoporosis","volume":"61","author":"Greenspan","year":"2000","journal-title":"Am. Fam. Physician"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1200\/JCO.2000.18.6.1378","article-title":"American society of clinical oncology guideline on the role of bisphosphonates in breast cancer","volume":"18","author":"Hillner","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1172\/JCI112400","article-title":"Serum bone gamma carboxyglutamic acid-containing protein in primary hyperthyroidism and in malignant hypercalcemia","volume":"77","author":"Delmas","year":"1986","journal-title":"J. Clin. Investig."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jbmr.5650030314","article-title":"Quantitative bone histomorphometry in nude mice bearing a human squamous cell lung cancer","volume":"3","author":"Kukreja","year":"1998","journal-title":"J. Bone Min. Res."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00003086-198209000-00004","article-title":"Mechanisms of lytic and blastic metastatic disease of bone","volume":"169","author":"Galasko","year":"1982","journal-title":"Clin. Orthop."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1677\/erc.0.0070271","article-title":"Mechanisms in the skeletal complications of breast cancer","volume":"7","author":"Martin","year":"2000","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"20113","DOI":"10.18632\/oncotarget.15390","article-title":"Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions","volume":"8","author":"Fioramonti","year":"2017","journal-title":"Oncotarget"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.bone.2015.08.003","article-title":"Rapid modification of the bone microenvironment following short-term treatment with cabozantinib in vivo","volume":"81","author":"Haider","year":"2015","journal-title":"Bone"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1158\/1078-0432.CCR-13-0839","article-title":"Cabozantinib inhibits prostate cancer growth and prevents tumor-induced bone lesions","volume":"20","author":"Dai","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1200\/JCO.2018.36.6_suppl.225","article-title":"Cabozantinib for metastatic castration-resistant prostate cancer (mcrpc) following docetaxel: Combined analysis of two phase iii trials","volume":"36","author":"Pond","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1200\/JCO.2015.65.5597","article-title":"Phase iii study of cabozantinib in previously treated metastatic castration-resistant prostate cancer: Comet-1","volume":"34","author":"Smith","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"44824","DOI":"10.1038\/srep44824","article-title":"Alteration of osteoblast arrangement via direct attack by cancer cells: New insights into bone metastasis","volume":"7","author":"Kimura","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1242\/jcs.183772","article-title":"Cadherin-11 is a novel regulator of extracellular matrix synthesis and tissue mechanics","volume":"129","author":"Row","year":"2016","journal-title":"J. Cell Sci."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"10909","DOI":"10.1038\/ncomms10909","article-title":"Cadherin-11 localizes to focal adhesions and promotes cell\u2013substrate adhesion","volume":"7","author":"Langhe","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"15851","DOI":"10.1074\/jbc.M111.281832","article-title":"The gap junction channel protein connexin 43 is covalently modified and regulated by sumoylation","volume":"287","author":"Kjenseth","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/jbmr.1825","article-title":"Degree of biological apatite c-axis orientation rather than bone mineral density controls mechanical function in bone regenerated using recombinant bone morphogenetic protein-2","volume":"28","author":"Ishimoto","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1242\/jeb.02304","article-title":"The influence of collagen fiber orientation and other histocompositional characteristics on the mechanical properties of equine cortical bone","volume":"209","author":"Skedros","year":"2006","journal-title":"J. Exp. Biol."},{"key":"ref_257","doi-asserted-by":"crossref","unstructured":"Shiraishi, A., Miyabe, S., Nakano, T., Umakoshi, Y., Ito, M., and Mihara, M. (2009). The combination therapy with alfacalcidol and risedronate improves the mechanical property in lumbar spine by affecting the material properties in an ovariectomized rat model of osteoporosis. BMC Musculoskelet. Disord., 10.","DOI":"10.1186\/1471-2474-10-66"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"42084","DOI":"10.1074\/jbc.M112.377515","article-title":"Mir-218 directs a wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells","volume":"287","author":"Hassan","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"79688","DOI":"10.18632\/oncotarget.12939","article-title":"Breast cancer cells obtain an osteomimetic feature via epithelial-mesenchymal transition that have undergone bmp2\/runx2 signaling pathway induction","volume":"7","author":"Tan","year":"2016","journal-title":"Oncotarget"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10585-013-9626-1","article-title":"Osteoblasts stimulate the osteogenic and metastatic progression of castration-resistant prostate cancer in a novel model for in vitro and in vivo studies","volume":"31","author":"Jennbacken","year":"2014","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00223-017-0365-1","article-title":"Osteomimicry: How the seed grows in the soil","volume":"102","author":"Rucci","year":"2018","journal-title":"Calcif. Tissue Int."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1349-7006.2009.01356.x","article-title":"Independent and cooperative roles of tumor necrosis factor-alpha, nuclear factor-kappab, and bone morphogenetic protein-2 in regulation of metastasis and osteomimicry of prostate cancer cells and differentiation and mineralization of mc3t3-e1 osteoblast-like cells","volume":"101","author":"Graham","year":"2010","journal-title":"Cancer Sci."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/10\/6\/182\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:07:15Z","timestamp":1760195235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/10\/6\/182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,4]]},"references-count":262,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6]]}},"alternative-id":["cancers10060182"],"URL":"https:\/\/doi.org\/10.3390\/cancers10060182","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,4]]}}}